Jeffrey K Aronson
MA DPhil FRCP HonFBPhS HonFFPM
Consultant Physician and Clinical Pharmacologist
Research
- Methods of classifying, detecting, and reporting adverse drug reactions, including systematic reviews, meta-analyses, and the use of anecdotal reports
- Innovation in drug therapy
- Monitoring therapy in chronic disease
- Systematic reviews of pharmacokinetics, pharmacodynamics, and pharmacokinetic–pharmacodynamic modelling
- The role of mechanisms in the philosophy of evidence-based medicine
- Linguistic aspects of medicine and pharmacology
Teaching and training
- Teaching medical students the fundamentals of therapeutics.
- Ad hoc two-week special study modules in clinical pharmacology and therapeutics for medical students.
- Masterclass in prescribing for medical students
- Co-author of didactic textbooks (e.g. “The Oxford Handbook of Practical Drug Therapy”) and contributor of chapters to others
- Editor, Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (16th edition, 2015) and of its annual updates, Side Effects of Drugs Annuals 1-35
- Co-editor (with John Talbot), Stephens’ Detection and Evaluation of Adverse Drug Reactions: Principles and Practice. 6th edition
Policy
- President Emeritus, Honorary Fellow, and Vice-President Publications, British Pharmacological Society; Vice President Publications
- Member of the Advisory Board of the British National Formulary
- Chairman of the British Pharmacopoeia Commission’s Expert Advisory Group on Nomenclature
Key publications
-
Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: A systematic investigation and analysis
Journal article
Onakpoya IJ. et al, (2015), BMC Medicine, 13
-
Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - A systematic review and meta-analysis
Journal article
Hirst JA. et al, (2015), British Journal of Clinical Pharmacology, 79, 733 - 743
-
The law of mass action and the pharmacological concentration-effect curve: Resolving the paradox of apparently non-dose-related adverse drug reactions
Journal article
Aronson JK. and Ferner RE., (2016), British Journal of Clinical Pharmacology, 81, 56 - 61
-
Joining the DoTS: new approach to classifying adverse drug reactions.
Journal article
Aronson JK. and Ferner RE., (2003), BMJ, 327, 1222 - 1225
-
EIDOS: a mechanistic classification of adverse drug effects.
Journal article
Ferner RE. and Aronson JK., (2010), Drug Saf, 33, 15 - 23
-
Toward standardized reporting of drug interactions: The READI checklist for anecdotal reports
Journal article
Aronson JK., (2015), Expert Review of Clinical Pharmacology, 8, 399 - 409
-
The need for randomization in animal trials: An overview of systematic reviews
Journal article
Hirst JA. et al, (2014), PLoS ONE, 9
-
Can understanding mechanisms solve the problem of extrapolating from study to target populations (the problem of 'external validity')?
Journal article
Howick J. et al, (2013), Journal of the Royal Society of Medicine, 106, 81 - 86
-
Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
Journal article
Aronson JK., (2013), Drug Saf, 36, 147 - 153
-
A new taxonomy for describing and defining adherence to medications
Journal article
Vrijens B. et al, (2012), British Journal of Clinical Pharmacology, 73, 691 - 705
Recent publications
-
A systematic narrative review of coroners’ prevention of future deaths reports (PFDs): a potential metric for patient safety in hospitals
Preprint
Bremner BT. et al, (2023)
-
When I use a word . . . Medical definitions: Goldfinger events
Journal article
Aronson JK., (2023), BMJ, p1161 - p1161
-
CARE Guidelines for Case Reports: Explanation and Elaboration Document. Translation into Russian
Journal article
Riley DS. et al, (2023), Current Pediatrics, 22, 88 - 108
-
When I use a word . . . Medical definitions: Pharmacovigilance signals.
Journal article
Aronson JK., (2023), BMJ (Clinical research ed.), 381
-
When I use a word . . . Medical definitions: Pharmacovigilant surveillance.
Journal article
Aronson JK., (2023), BMJ, 381
-
When I use a word . . . Medical definitions: adverse events, effects, and reactions.
Journal article
Aronson JK., (2023), BMJ, 381
-
When I use a word . . . Medical definitions: Pharmacovigilance.
Journal article
Aronson JK., (2023), BMJ, 381
-
When I use a word . . . .Devising bioscience definitions.
Journal article
Aronson JK., (2023), BMJ, 380
-
When I use a word . . . .Diagnosing definitions.
Journal article
Aronson JK., (2023), BMJ, 380
-
When I use a word . . . . Defining with finesse
Journal article
Aronson JK., (2023), BMJ, p649 - p649